4D Molecular Therapeutics, Inc. has grown revenue 201% a year over three years and 44% a year over five. Revenue growth, 3-year annual rate: +201% (Biotechnology median +17%). Revenue growth, 5-year rate: +44%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

FDMT4D Molecular Therapeutics, Inc.

Healthcare

$12.69+53% 1Y

$12.69

$7.1952 weeks$16.74

Is it growing?

Is FDMT growing?

4D Molecular Therapeutics, Inc. has grown revenue 201% a year over three years and 44% a year over five.

+201%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +44%
Revenue growth, 5-year rate · +201% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›